The Relative Strength (RS) Rating for Hinge Health entered a new percentile Tuesday, with a rise from 76 to 81.
Risk Management In The Stock Market: How Much Money To Invest Now
IBD's proprietary RS Rating tracks technical performance by showing how a stock's price action over the last 52 weeks measures up against that of the other stocks in our database.
Over 100 years of market history reveals that the best-performing stocks tend to have an RS Rating north of 80 as they begin their biggest runs.
Now is not an ideal time to jump in since it isn't near a proper buy zone, but see if the stock goes on to form a consolidation and break out.
The company showed 0% earnings growth last quarter. Revenue rose 50%.
The company holds the No. 9 rank among its peers in the Medical-Products industry group. Boston Scientific, Insulet and LifeMD are among the top 5 highly rated stocks within the group.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
RELATED:
Which Stocks Are Showing Rising Relative Strength?
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
